研究单位：[1]Beijing InnoCare Pharma Tech Co., Ltd.[2]The First Affiliated Hospital of Bengbu Medical College,Bengbu,Anhui,China[3]Anhui Provincial Cancer Hospital,Hefei,Anhui,China[4]The First Affiliated Hospital of Anhui Medical University,Hefei,Anhui,China[5]The Fifth Medical Center of PLA General Hospital,Beijing,Beijing,China[6]The First Affiliated Hospital of Congqing Medical University,Chongqing,Chongqing,China,400000[7]The Second Affiliated Hospital of Army Medical University,Chongqing,Chongqing,China[8]The First Affiliated Hospital of Xiamen University,Xiamen,Fujian,China[9]Lanzhou University Second Hospital,Lanzhou,Gansu,China[10]Dongguan People's Hospital,Dongguan,Guangdong,China,523058[11]Cancer Prevention and Treatment Center, Sun Yat-sen University,Guangzhou,Guangdong,China[12]Guangzhou First People's Hospital,Guangzhou,Guangdong,China[13]Shenzhen People's Hospital,Shenzhen,Guangdong,China[14]Affiliated Hospital of Guilin Medical College,Guilin,Guangxi Zhuang Autonomous Region,China,541000[15]Affiliated Hospital of Hebei University,Baoding,Hebei,China[16]Hebei Medical University Second Hospital,Shijiazhuang,Hebei,China,h[17]The Fourth Hospital of Hebei Medical University,Shijiazhuang,Hebei,China[18]Affiliated Tumor Hospital of Harbin Medical University,Ha'erbin,Heilongjiang,China[19]The first Affiliated Hospital of Henan University of Science and Technology,Luoyang,Henan,China[20]First Affiliated Hospital of Zhengzhou University,Zhengzhou,Henan,China[21]Henan Cancer Hospital,Zhengzhou,Henan,China[22]Henan Province Hospital,Zhengzhou,Henan,China[23]Zhongnan Hospital of WuHan University,Wuhan,Hubei,China,430071[24]Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology,Wuhan,Hubei,China[25]Yichang Central People's Hospital,Yichang,Hubei,China[26]Yichang First People's Hospital,Yichang,Hubei,China[27]The Second Xiangya Hospital of Central South University,Changsha,Hunan,China,410000[28]The Third Xiangya Hospital of Central South University,Changsha,Hunan,China[29]Zhuzhou Central Hospital,Zhuzhou,Hunan,China,412007[30]Jiangsu Province Hospital,Nanjing,Jiangsu,China[31]The First Affiliated Hospital of Soochow University,Suzhou,Jiangsu,China[32]Wuxi People's Hospital,Wuxi,Jiangsu,China[33]Affiliated Hospital of Xuzhou Medical University,Xuzhou,Jiangsu,China[34]Subei People's Hospital,Yangzhou,Jiangsu,China[35]The First Affiliated Hospital of Gannan Medical College,Ganzhou,Jiangxi,China,341004[36]Jiangxi Cancer Hospital,Nanchang,Jiangxi,China[37]The First Affiliated Hospital of Nanchang University,Nanchang,Jiangxi,China[38]Shengjing Hospital of China Medical University,Dalian,Liaoning,China[39]The First Affiliated Hospital of China Medical University,Shenyang,Liaoning,China[40]Affiliated Hospital of Binzhou Medical College,Binzhou,Shandong,China[41]Shandong Cancer Hospita,Jinan,Shandong,China,250117[42]Shandong Provincial Hospital,Jinan,Shandong,China[43]Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai,Shanghai,China,200025[44]The Second Affiliated Hospital of Xi´an Jiaotong University,Xi'an,Shanxi,China,710000[45]Sichuan Provincial People's Hospital,Chengdu,Sichuan,China[46]West China Hospital of Sichuan University,Chengdu,Sichuan,China[47]Yibin Second People's Hospital,Yibin,Sichuan,China[48]General Hospital of Tianjin Medical University,Tianjin,Tianjin,China[49]Hospital of Hematology, Chinese Academy of Medical Sciences,Tianjin,Tianjin,China[50]Tianjin Cancer Hospital,Tianjin,Tianjin,China[51]The First Affiliated Hospital of Xinjiang Medical University,Ürümqi,Xinjiang Uygur Autonomous Region,China,830011[52]The first Affiliated Hospital of Kunming Medical University,Kunming,Yunnan,China[53]Dongyang People's Hospital,Dongyang,Zhejiang,China,322199[54]Shaoyifu Hospital Affiliated to Zhejiang University School of Medicine,Hangzhou,Zhejiang,China,310026
研究目的：
This is a randomized, multicenter, open-label, Phase 3 study to evaluate the efficacy and safety of ICP-022 versus Chlorambucil plus Rituximab in subjects with Previously Untreated Chronic Lymphocytic Leukemia.
